SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $38,644,000 | -18.7% | 5,166,290 | +17.9% | 0.02% | -22.6% |
| Q4 2020 | $47,545,000 | +28.6% | 4,381,992 | +4.8% | 0.03% | +24.0% |
| Q3 2020 | $36,972,000 | -26.6% | 4,182,346 | -11.5% | 0.02% | -30.6% |
| Q2 2020 | $50,366,000 | +72.5% | 4,724,774 | -4.1% | 0.04% | +44.0% |
| Q1 2020 | $29,206,000 | -15.0% | 4,925,206 | -1.0% | 0.02% | -7.4% |
| Q4 2019 | $34,375,000 | -28.5% | 4,974,662 | +7.4% | 0.03% | -35.7% |
| Q3 2019 | $48,099,000 | +226.9% | 4,633,773 | +191.6% | 0.04% | +223.1% |
| Q2 2019 | $14,715,000 | +135.2% | 1,589,045 | +132.2% | 0.01% | +116.7% |
| Q1 2019 | $6,256,000 | – | 684,475 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |